Press

Enjoy a showcase of all things weird. BUFFALO, N.Y., July 15, 2025 /PRNewswire/ — Brace yourselves for the strangest and most exciting event of the year as The Oddities and Curiosities Expo, the ultimate celebration of all things peculiar and extraordinary, returns to Buffalo Niagara Convention Center in Buffalo, NY on August 2nd and 3rd. […]

New HarrisX Poll Shows Open and Competitive Field in Four- and Three- Candidate Race Permutations Cuomo Leads Mamdani in a Head-to-Head Race by 15 Points NEW YORK, July 15, 2025 /PRNewswire/ — A new poll from HarrisX finds the New York City mayoral race shaping up to be a tight and competitive contest, with Assemblymember Zohran

SAN DIEGO, July 15, 2025 /PRNewswire/ — Robbins Geller Rudman & Dowd LLP announces that it has filed a class action lawsuit seeking to represent purchasers of Organon & Co. (NYSE: OGN) publicly traded securities between November 3, 2022 and April 30, 2025, both dates inclusive (the “Class Period”).  Captioned Lerner v. Organon & Co., No.

SAN DIEGO, July 15, 2025 /PRNewswire/ — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of XPLR Infrastructure, LP f/k/a NextEra Energy Partners, LP (NYSE: XIFR) securities between September 27, 2023 and January 27, 2025, both dates inclusive (the “Class Period”), have until September 8, 2025 to seek appointment

The menin inhibitor market is poised for rapid growth, with REVUFORJ setting the foundation and a strong pipeline of innovative, genetically targeted therapies on the horizon. With high levels of unmet need, particularly in NPM1-mutant and KMT2A-rearranged AML, this class is expected to play a critical role in the next generation of precision oncology therapies